More policy work is needed to prevent future supply-chain disruptions and prioritize key drugs at the greatest risk for shortage, the authors say.
List of drugs that "when medically needed in acute care must be available and used within hours or days of the need or the patient may suffer serious outcomes which may include disability or death." Check the dashboards for the most recent shortages, or at the complete PDF list, updated every week.
Get Resilient Drug Supply updates in your inbox.
Researchers estimate Canada's potential demand for tocilizumab, a potential COVID-19 drug.
Vaccines are just one of many COVID-disrupted services, a recent survey notes.
Should studies show COVID-19 effectiveness, fluvoxamine's supply chain looks resilient, an expert says.
In spite of an increase in days of supply, data still show discontinuation of some drugs.
Operation Warp Speed halted Tepezza manufacturing, but supplies of the drug will return this month.
The WHO and its partners will assess shortages of raw materials like plastic, glass, stoppers, and vials.
GAO emphasizes addressing the backlog, pre-announced inspections, and alternative approaches.
Low-resource nations have borne the brunt of shaky oxygen supply chains, even before COVID.
Experts in health-system pharmacy say the potential for major disruptions will increase.
Demand surges in pharmacy and hospital prescriptions reflect early changes in COVID treatment.